Opus Genetics Inc (NASDAQ:IRD) price on Thursday, July 03, rose 1.01% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.0.
A look at the stock’s price movement, the close in the last trading session was $0.99, moving within a range at $0.9801 and $1.02. The beta value (5-Year monthly) was 0.29. Turning to its 52-week performance, $2.18 and $0.65 were the 52-week high and 52-week low respectively. Overall, IRD moved -0.99% over the past month.
Opus Genetics Inc’s market cap currently stands at around $59.66 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-15.
Turning to the stock’s technical picture we see that short term indicators suggest on average that IRD is a 50% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
IRD’s current price about 2.68% and 3.57% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 53.99, while 7-day volatility ratio is 7.08% and 7.10% in the 30-day chart. Further, Opus Genetics Inc (IRD) has a beta value of -0.01.
If we refocus on Opus Genetics Inc (NASDAQ:IRD), historical trading data shows that trading volumes averaged 1.22 over the past 10 days and 1.06 million over the past 3 months. The company’s latest data on shares outstanding shows there are 45.48 million shares.
The 50.72% of Opus Genetics Inc’s shares are in the hands of company insiders while institutional holders own 22.78% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.49 million on 2025-06-13, giving us a short ratio of 0.24. The data shows that as of 2025-06-13 short interest in Opus Genetics Inc (IRD) stood at 86.0 of shares outstanding, with shares short rising to 0.23 million registered in 2025-05-15. Current price change has pushed the stock -37.11% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IRD stock continues to rise going into the next quarter.
